Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Pradier

Showing results (91-100 of 163) with videos related to

Pageof 17
Sort By:
Frontiers in Medicine|April 30, 2025
Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIVMatteo Vassallo, Jacques Durant, Sami Addou, et al.
The Journal of Rheumatology|March 17, 2011
Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot studyChristian H Roux, Veronique Breuil, Laure Valerio, et al.
Cancer Epidemiology|August 20, 2011
Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008Laurent Bailly, Bernard Giusiano, Eugènia Mariné Barjoan, et al.
Journal of Neurovirology|July 13, 2013
Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt studyMatteo Vassallo, Brigitte Dunais, Jacques Durant, et al.
Frontiers in Medicine|March 29, 2021
Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid TumorsMatteo Vassallo, Celine Michelangeli, Roxane Fabre, et al.
Healthcare (Basel, Switzerland)|June 26, 2026
Patient Experience and Caregiver Involvement in COVID-19 Care Pathways: Revealing System Blind Spots Through a Life-Events Calendar ApproachRomain Lutaud, Juliette Mirouse, Manon Borg, et al.
HIV Clinical Trials|April 3, 2003
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled studyChristian Pradier, Laurence Bentz, Bruno Spire, et al.
Annales De Pathologie|April 15, 2009
[Data quality of cancer registration by Adicap codes, used by French pathologists from Paca, 2005-2006]Laurent Bailly, Eugènia Mariné-Barjoan, Damien Ambrosetti, et al.
AIDS (London, England)|January 30, 2014
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?Matteo Vassallo, Jacques Durant, Virginie Biscay, et al.
Pathogens (Basel, Switzerland)|June 25, 2025
The Effects of High-Dose Probiotic Supplementation on Immune Activation and Neurocognitive Disorders in People Living with HIV Undergoing Successful Antiretroviral Treatment: The Procog StudyMatteo Vassallo, Margaux Zerlini, Roxane Fabre, et al.
Pageof 17

Showing results (91-100 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Medicine|April 30, 2025
Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIVMatteo Vassallo, Jacques Durant, Sami Addou, et al.
The Journal of Rheumatology|March 17, 2011
Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot studyChristian H Roux, Veronique Breuil, Laure Valerio, et al.
Cancer Epidemiology|August 20, 2011
Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008Laurent Bailly, Bernard Giusiano, Eugènia Mariné Barjoan, et al.
Journal of Neurovirology|July 13, 2013
Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt studyMatteo Vassallo, Brigitte Dunais, Jacques Durant, et al.
Frontiers in Medicine|March 29, 2021
Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid TumorsMatteo Vassallo, Celine Michelangeli, Roxane Fabre, et al.
Healthcare (Basel, Switzerland)|June 26, 2026
Patient Experience and Caregiver Involvement in COVID-19 Care Pathways: Revealing System Blind Spots Through a Life-Events Calendar ApproachRomain Lutaud, Juliette Mirouse, Manon Borg, et al.
HIV Clinical Trials|April 3, 2003
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled studyChristian Pradier, Laurence Bentz, Bruno Spire, et al.
Annales De Pathologie|April 15, 2009
[Data quality of cancer registration by Adicap codes, used by French pathologists from Paca, 2005-2006]Laurent Bailly, Eugènia Mariné-Barjoan, Damien Ambrosetti, et al.
AIDS (London, England)|January 30, 2014
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?Matteo Vassallo, Jacques Durant, Virginie Biscay, et al.
Pathogens (Basel, Switzerland)|June 25, 2025
The Effects of High-Dose Probiotic Supplementation on Immune Activation and Neurocognitive Disorders in People Living with HIV Undergoing Successful Antiretroviral Treatment: The Procog StudyMatteo Vassallo, Margaux Zerlini, Roxane Fabre, et al.
Pageof 17